SCHEMBL8982196

SCHEMBL8982196

O=C(O)CCC(=O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 17/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5673556 0.90 TBXA2R (0.85) TBXA2R
SCHEMBL8757930 0.88 TBXA2R (0.82) TBXA2R
SCHEMBL8757098 0.86 TBXA2R (0.83) TBXA2R
SCHEMBL1652950 0.86 TBXA2R (1.00) TBXA2R
SCHEMBL8758409 0.85 TBXA2R (0.83) TBXA2R
Water SCHEMBL1561746 0.85 TBXA2R (0.98) TBXA2R
SCHEMBL8758625 0.84 TBXA2R (0.81) TBXA2R
SCHEMBL8758408 0.83 TBXA2R (0.72) TBXA2R
SCHEMBL8757810 0.81 TBXA2R (0.84) TBXA2R
SCHEMBL8731670 0.80 TBXA2R (0.82) TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0589037-B1 INDIAN DERIVATIVE AND THROMBOXANE ANTAGONIST CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-05-29 EP disclosed
US-5409956-A A sulfonylaminoalkylindan carboxylic acid or ester for treating thrombosis, vasospasm or asthma ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
EP-0589037-A1 INDIAN DERIVATIVE AND THROMBOXANE ANTAGONIST CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1994-03-30 EP disclosed